Henry H. Armstrong Associates’s Bausch Health BHC Stock Holding History

Henry H. Armstrong Associates’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$256K	Sell	43,935 -280	-0.6%	-$1.61K	0.02%	57
2026 Q2	$218K	Hold	44,215	–	–	0.02%	63
2026 Q1	$239K	Hold	44,215	–	–	0.02%	56
2025 Q4	$307K	Hold	44,215	–	–	0.03%	51
2025 Q3	$285K	Hold	44,215	–	–	0.03%	53
2025 Q2	$294K	Hold	44,215	–	–	0.03%	51
2025 Q1	$286K	Hold	44,215	–	–	0.03%	52
2024 Q4	$356K	Hold	44,215	–	–	0.04%	48
2024 Q3	$361K	Hold	44,215	–	–	0.03%	52
2024 Q2	$308K	Hold	44,215	–	–	0.03%	52
2024 Q1	$469K	Hold	44,215	–	–	0.05%	44
2023 Q4	$355K	Hold	44,215	–	–	0.04%	46
2023 Q3	$363K	Hold	44,215	–	–	0.04%	46
2023 Q2	$354K	Sell	44,215 -90	-0.2%	-$664	0.04%	46
2023 Q1	$359K	Hold	44,305	–	–	0.04%	48
2022 Q4	$278K	Sell	44,305 -11,790	-21%	-$82.3K	0.03%	51
2022 Q3	$386K	Hold	56,095	–	–	0.05%	50
2022 Q2	$469K	Hold	56,095	–	–	0.06%	47
2022 Q1	$1.28M	Hold	56,095	–	–	0.14%	33
2021 Q4	$1.55M	Sell	56,095 -9,430	-14%	-$252K	0.16%	35
2021 Q3	$1.82M	Hold	65,525	–	–	0.21%	31
2021 Q2	$1.92M	Hold	65,525	–	–	0.22%	30
2021 Q1	$2.08M	Hold	65,525	–	–	0.26%	30
2020 Q4	$1.36M	Sell	65,525 -8,350	-11%	-$156K	0.18%	36
2020 Q3	$1.15M	Hold	73,875	–	–	0.16%	34
2020 Q2	$1.35M	Hold	73,875	–	–	0.2%	32
2020 Q1	$1.15M	Sell	73,875 -120	-0.2%	-$2.89K	0.19%	32
2019 Q4	$2.21M	Sell	73,995 -1,310	-2%	-$34.1K	0.32%	26
2019 Q3	$1.65M	Hold	75,305	–	–	0.27%	25
2019 Q2	$1.9M	Sell	75,305 -17,345	-19%	-$412K	0.26%	24
2019 Q1	$2.29M	Hold	92,650	–	–	0.35%	26
2018 Q4	$1.71M	Sell	92,650 -288	-0.3%	-$6.85K	0.28%	27
2018 Q3	$2.39M	Hold	92,938	–	–	0.37%	25
2018 Q2	$2.16M	Buy	92,938 +490	+0.5%	+$10.1K	0.37%	24
2018 Q1	$1.59M	Hold	92,448	–	–	0.26%	30
2017 Q4	$1.92M	Sell	92,448 -1,010	-1%	-$16K	0.32%	26
2017 Q3	$1.34M	Sell	93,458 -295	-0.3%	-$4.46K	0.24%	30
2017 Q2	$1.62M	Buy	93,753 +295	+0.3%	+$3.54K	0.31%	28
2017 Q1	$1.03M	Sell	93,458 -290	-0.3%	-$3.99K	0.2%	32
2016 Q4	$1.36M	Sell	93,748 -149,187	-61%	-$2.74M	0.28%	29
2016 Q3	$5.96M	Sell	242,935 -29,157	-11%	-$755K	1.15%	12
2016 Q2	$5.48M	Buy	272,092 +490	+0.2%	+$13.9K	1.1%	13
2016 Q1	$7.14M	Buy	271,602 +18,695	+7%	+$1.38M	1.47%	12
2015 Q4	$25.7M	Buy	252,907 +54,633	+28%	+$6.14M	5.03%	9
2015 Q3	$35.4M	Buy	+198,274	New	+$46.2M	7.24%	8

Other funds holding BHC

Addenda Capital Montreal, Quebec, Canada $3.78B AUM 23.53% 1-Year Est. Return

MAM

Marotta Asset Management Charlottesville, Virginia $589M AUM 14.57% 1-Year Est. Return

Roxbury Financial Mount Arlington, New Jersey $130M AUM 20.04% 1-Year Est. Return

IRC

Investors Research Corp Atlanta, Georgia $569M AUM 15.41% 1-Year Est. Return

GWM

GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return

BWM

Bullock Wealth Management Bloomington, Indiana $241M AUM 23.31% 1-Year Est. Return

AAG

Armstrong Advisory Group Needham, Massachusetts $1.66B AUM 13.15% 1-Year Est. Return

TFA

Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Henry H. Armstrong Associates's BHC Position: Q3 2026 in Review

Henry H. Armstrong Associates reduced its Bausch Health (BHC) stake by 0.63% in Q3 2026, selling an estimated $1.61K and leaving 43,935 shares worth $256K. The position accounts for 0.02% of the portfolio, ranked #57.

Henry H. Armstrong Associates first reported a position in BHC in Q3 2015 and has held it in 45 quarters since. The position peaked at $35.4M in Q3 2015. 10 funds tracked by Wall St. Rank hold BHC as of Q3 2026.

Henry H. Armstrong Associates held 43,935 shares of Bausch Health worth $256K as of Q3 2026.
Henry H. Armstrong Associates sold 280 Bausch Health shares in Q3 2026, an estimated $1.61K.
Bausch Health made up 0.02% of Henry H. Armstrong Associates's portfolio in Q3 2026, its #57 holding.
Henry H. Armstrong Associates first reported a position in Bausch Health in Q3 2015 and has held it in 45 quarters since.
Henry H. Armstrong Associates's Bausch Health position peaked at $35.4M in Q3 2015.
10 funds tracked by Wall St. Rank held Bausch Health as of Q3 2026.

Based on Henry H. Armstrong Associates's 13F filing for Q3 2026, filed 7 Oct 2026.